Ontology highlight
ABSTRACT: Objective
To determine the efficacy of high dose folic acid supplementation for prevention of pre-eclampsia in women with at least one risk factor: pre-existing hypertension, prepregnancy diabetes (type 1 or 2), twin pregnancy, pre-eclampsia in a previous pregnancy, or body mass index ≥35.Design
Randomised, phase III, double blinded international, multicentre clinical trial.Setting
70 obstetrical centres in five countries (Argentina, Australia, Canada, Jamaica, and UK).Participants
2464 pregnant women with at least one high risk factor for pre-eclampsia were randomised between 2011 and 2015 (1144 to the folic acid group and 1157 to the placebo group); 2301 were included in the intention to treat analyses.Intervention
Eligible women were randomised to
SUBMITTER: Wen SW
PROVIDER: S-EPMC6133042 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature